RECURRENT PLASMA CELL MYELOMA
Clinical trials for RECURRENT PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for RECURRENT PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood cancer transplant study tests safer GVHD prevention
Disease control TerminatedThis study looked at people with blood cancers receiving a stem cell transplant from an unrelated donor. The goal was to compare two drug combinations (cyclosporine plus sirolimus with either MMF or post-transplant cyclophosphamide) to prevent graft-versus-host disease (GVHD), a …
Matched conditions: RECURRENT PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:33 UTC
-
Cancer combo shows promise in myeloma maintenance trial
Disease control TerminatedThis study looked at whether combining two drugs, daratumumab and pomalidomide, could help keep multiple myeloma from coming back in patients who had already relapsed after a stem cell transplant. The 13 participants received the drug combination as maintenance therapy after a se…
Matched conditions: RECURRENT PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:17 UTC